BiottsS.A.Active
Research and experimental development on biotechnology
KRS: 0000738948 NIP: 8992847381 REGON: 36942973400000
Overview
Registry date
2018-07-05
Share capital
$84,324.42
Activity description
Biotts is a biotech company specializing in transdermal drug delivery systems, utilizing their proprietary Multifunctional Transdermal Carrier Y (MTC-Y™) technology. This technology enables the transdermal delivery of larger molecules, such as peptides and proteins, up to 6,000 Da, improving bioavailability and offering a needle-free administration alternative. Biotts develops its own transdermal drug products and collaborates with the pharmaceutical industry for technical development.
Registered address
Ul. Wrocławska 44C, 55-040 Bielany Wrocławskie, Poland
Website
biotts.comWebsite active
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-03-02.Active
- 02 1090 1522 0000 0001 4322 7798
- 68 1090 1522 0000 0001 5634 8091
- 12 1090 2473 0000 0001 3587 4256
Authorized Representatives
Ownership
Subsidiaries
| Name | Shares | Share value | % in company | |
|---|---|---|---|---|
| NGD Pharmasp. z o.o. | 1,028 | 13,884.39 USD | 100% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| GenxoneS.A. | $542,750.94 | genxone.eu | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| Medicofarma BiotechS.A. | $330,956.61 | medicofarmabiotech.pl | |
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu | |
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl/contact/wpdsa/ | |
| DigitmedS.A. | $64,087.41 | digitmed.pl |
FAQ
Last updated: 2026-06-12